华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300676 华大基因

已收盘 05-24 15:00:00

{"stockData":{"symbol":"300676","market":"SZ","secType":"STK","nameCN":"华大基因","latestPrice":39.2,"timestamp":1716534195000,"preClose":39.6,"halted":0,"volume":1622300,"delay":0,"floatShares":411000000,"shares":413999999,"eps":0.1546,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.4,"latestTime":"05-24 15:00:00","open":40.18,"high":40.18,"low":39.2,"amount":64012500,"amplitude":0.0247,"askPrice":39.23,"askSize":3,"bidPrice":39.2,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.1546,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716773400000},"adr":0,"adjPreClose":39.6,"symbolType":"stock","openAndCloseTimeList":[[1716514200000,1716521400000],[1716526800000,1716534000000]],"highLimit":43.56,"lowLimit":35.64,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":413914325,"pbRate":1.66,"roa":"--","roe":"0.13%","epsLYR":0.2266,"committee":0.07027,"marketValue":16225000000,"floatMarketCap":16108000000,"peRate":253.557577,"changeRate":-0.0101,"turnoverRate":0.0039,"status":1},"requestUrl":"/m/hq/s/300676/wiki","defaultTab":"wiki","newsList":[{"id":"2436122222","title":"华大基因(300676.SZ)：BRCA1/2基因突变检测试剂盒(联合探针锚定聚合测序法)终止注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2436122222","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2436122222?lang=zh_cn&edition=full","pubTime":"2024-05-20 16:59","pubTimestamp":1716195572,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华大基因 公告，公司全资子公司华大生物科技(武汉)有限公司的BRCA1/2基因突变检测试剂盒于2018年7月通过了国家药品监督管理局的创新医疗器械特别审批，2020年6月其注册申请获得国家药品监督管理局颁发的《受理通知书》。公司及武汉生物科技高度重视该产品的注册事项，将在完成剩余受试者药效随访后重新向国家药品监督管理局提交注册申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1123253.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430797422","title":"华大基因(300676)3月31日股东户数6.79万户，较上期减少2.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430797422","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430797422?lang=zh_cn&edition=full","pubTime":"2024-04-27 17:19","pubTimestamp":1714209581,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华大基因披露，截至2024年3月31日公司股东户数为6.79万户，较12月31日减少1822.0户，减幅为2.62%。在医疗服务行业个股中，华大基因股东户数高于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.14万户。从股价来看，2023年12月31日至2024年3月31日，华大基因区间跌幅为14.73%，在此期间股东户数减少1822.0户，减幅为2.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700025617.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430535784","title":"图解华大基因一季报：第一季度单季净利润同比减69.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430535784","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430535784?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:11","pubTimestamp":1714155106,"startTime":"0","endTime":"0","summary":"证券之星消息，华大基因2024年一季报显示，公司主营收入8.21亿元，同比下降13.99%；归母净利润1240.25万元，同比下降69.91%；扣非净利润227.76万元，同比下降92.69%；负债率25.37%，投资收益-124.59万元，财务费用-1019.73万元，毛利率49.2%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700003817.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430136273","title":"华大基因(300676.SZ)发布一季度业绩，净利润1240.25万元，同比减少69.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430136273","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430136273?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:56","pubTimestamp":1714132611,"startTime":"0","endTime":"0","summary":"华大基因(300676.SZ)发布2024年第一季度报告，公司于报告期内实现营业收...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/23.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112168.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426865784","title":"华大基因(300676.SZ)发布2023年度业绩，净利润9290.04万元，下降88.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426865784","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2426865784?lang=zh_cn&edition=full","pubTime":"2024-04-12 20:45","pubTimestamp":1712925900,"startTime":"0","endTime":"0","summary":"华大基因发布2023年年度报告，该公司营业收入为43.5亿元，同比减少38.33%。归属于上市公司股东的净利润为9290.04万元，同比减少88.43%。基本每股收益为0.2266元。报告期内，受行业周期影响，公司相关检测业务收入出现较大下降。公司主动战略性调整主营业务产品结构与供应链策略，报告期内主营业务虽稳步发展，但整体营业收入规模同比缩减。报告期内公司研发投入占营业收入比重较上年同期有较大提升。公司按照权益法核算的投资收益较上年同期大幅下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarqtum8760271.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarqtum8760271.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2415590469","title":"华大基因业绩快报：2023年净利同比降88.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415590469","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2415590469?lang=zh_cn&edition=full","pubTime":"2024-02-29 17:22","pubTimestamp":1709198520,"startTime":"0","endTime":"0","summary":"　　华大基因2月29日晚间发布业绩快报，2023年实现营业总收入43.53亿元，同比下降38.29%；净利润9121.10万元，同比下降88.64%；基本每股收益0.22元。　　华大基因称，公司业绩较2022年度有较大下降，主要系报告期内，受行业周期影响，公司相关检测业务收入出现较大下降。　　盘面上，截至今日收盘，华大基因股价报44.22元，涨0.45%。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-02-29/doc-inakszmk8516888.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-02-29/doc-inakszmk8516888.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2415594025","title":"华大基因(300676.SZ)2023年度净利润9121.1万元 同比下降88.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415594025","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2415594025?lang=zh_cn&edition=full","pubTime":"2024-02-29 16:55","pubTimestamp":1709196900,"startTime":"0","endTime":"0","summary":"华大基因发布2023年度业绩快报，报告期内，公司预计实现营业收入43.53亿元，较上年同期下降38.29%;预计归属于上市公司股东的净利润为9121.1万元，较上年同期下降88.64%。报告期内，公司业绩较2022年度有较大下降，主要系报告期内，受行业周期影响，公司相关检测业务收入出现较大下降。同时积极应对市场变化，加大研发资源投入，保持持续的产品和技术创新，报告期内公司研发投入占营业收入比重较2022年度有较大提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inakszmn9418708.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inakszmn9418708.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413449054","title":"被踢出MSCI中国指数，华大基因前景如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2413449054","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2413449054?lang=zh_cn&edition=full","pubTime":"2024-02-21 18:58","pubTimestamp":1708513131,"startTime":"0","endTime":"0","summary":"北京时间2月13日，国际指数编制公司MSCI（明晟指数）宣布了其2024年度2月份的季度指数评审结果，包括华大基因（300676.SZ）在内的多家企业被剔出MSCI中国指数。入选MSCI中国指数的企业意味着较为突出的投资价值，全球基金经理也以MSCI指数作为重要的观察指标，而本次华大基因被剔除该指数，自然被市场解读为悲观的信号。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202402_1/97de3bc0-d3d8-42e1-9fed-00785ce5e54d.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202402_1/97de3bc0-d3d8-42e1-9fed-00785ce5e54d.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65d5d76bbde0b37037601b17","is_publish_highlight":false,"gpt_icon":0},{"id":"2407369613","title":"华大基因：2023年净利同比预降86.3%—90.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2407369613","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2407369613?lang=zh_cn&edition=full","pubTime":"2024-01-30 18:48","pubTimestamp":1706611680,"startTime":"0","endTime":"0","summary":"华大基因发布业绩预告，预计2023年归母净利8000万元—1.1亿元，同比下降86.3%—90.04%。业绩预降主要系公司主营业务综合毛利率有所下滑，以及研发投入增长所致。报告期内，受行业周期影响，公司相关检测业务收入较2022年同期出现较大下降，公司继续主动战略性调整主营业务产品结构与供应链策略，推进主营业务的稳步发展。其中，生育健康的业务和多组学的业务收入同比略有增长，肿瘤防控收入同比实现显著增长。               \n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-01-30/doc-inafiecc9998641.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-01-30/doc-inafiecc9998641.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2388234104","title":"华大基因(300676.SZ)向18名激励对象授予140万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2388234104","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2388234104?lang=zh_cn&edition=full","pubTime":"2023-12-01 20:40","pubTimestamp":1701434400,"startTime":"0","endTime":"0","summary":"华大基因(300676.SZ)发布公告，公司审议通过了《关于向2022年限制性股票激励计划激励对象授予预留限制性股票的议案》，确定本激励计划的预留授予日为2023年12月1日，向符合授予条件的18名激励对象授予140万股第二类限制性股票，授予价格为27.83元/股(调整后)。本次授予后，本激励计划预留部分限制性股票全部授予完毕。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-01/doc-imzwpmnn4051103.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-01/doc-imzwpmnn4051103.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-07-14","address":"广东省深圳市盐田区洪安三街21号华大综合园7栋7层-14层","stockEarnings":[{"period":"1week","weight":-0.0508},{"period":"1month","weight":0.0033},{"period":"3month","weight":-0.1077},{"period":"6month","weight":-0.2483},{"period":"1year","weight":-0.314},{"period":"ytd","weight":-0.1833}],"companyName":"深圳华大基因股份有限公司","boardCode":"AI0074","perCapita":"6056股","boardName":"专业技术服务业","registeredCapital":"41391万元","compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":0.0145},{"period":"3month","weight":0.028},{"period":"6month","weight":0.0158},{"period":"1year","weight":-0.0351},{"period":"ytd","weight":0.0383}],"survey":"　　深圳华大基因股份有限公司的主营业务为通过基因检测,质谱检测,生物信息分析等多组学大数据技术手段，为科研机构,企事业单位,医疗机构,社会卫生组织等提供研究服务和精准医学检测综合解决方案。公司主要产品包括孕期营养检测、人体氨基酸检测、人体维生素检测等。公司荣获“2022年度ESG最佳社会责任企业”、“2023医疗器械出海最佳战略布局企业”、“2022年度投资者关系金奖杰出IR公司”，“2023环境、社会及治理（ESG）年度案例”等多项社会荣誉或奖项，有效提升了公司的品牌知名度和影响力。","serverTime":1716718438509,"listedPrice":13.64,"stockholders":"67851人(较上一季度减少2.62%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华大基因,300676,华大基因股票,华大基因股票老虎,华大基因股票老虎国际,华大基因行情,华大基因股票行情,华大基因股价,华大基因股市,华大基因股票价格,华大基因股票交易,华大基因股票购买,华大基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华大基因(300676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华大基因(300676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}